Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Head and Neck Cancer

Free Subscription 17.11.2025 3 Am J Surg 3 BMC Cancer 2 Dis Esophagus 2 Histopathology 1 Hum Pathol 1 Int J Cancer 15 Oral Oncol 1 Otolaryngol Head Neck Surg 2 PLoS One 3 Radiother Oncol 2 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. SONG Z, Akund R, Wu C, Fazendin J, et al
   Performance of molecular testing for indeterminate thyroid nodules in Black patients.
   Am J Surg. 2025;250:116569.
   PubMed         Abstract available
   
   
2. LUI MS, Hangge PT, DeLozier O, Patel KN, et al
   More than just stuck in the middle: papillary thyroid cancer of the isthmus may present with aggressive features and nodal metasasis.
   Am J Surg. 2025;250:116621.
   PubMed         Abstract available
   
   
3. LIOU R, Slattery L, Hu Y, Kuo EJ, et al
   Short-term outcomes in radiofrequency ablation for the primary treatment of T1N0M0 papillary thyroid carcinomas.
   Am J Surg. 2025 Oct 31:116702. doi: 10.1016/j.amjsurg.2025.116702.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. EROGLU I, Mohring C, Sadeghlar F, Manczak A, et al
   Efficacy and safety of neoadjuvant FLOT treatment for resectable gastric/gastroesophageal junction adenocarcinoma in Turkish and German patients; a real-world data.
   BMC Cancer. 2025;25:1754.
   PubMed         Abstract available
   
   
5. YANG P, Liu S, Chen X, Xin H, et al
   Muscle-specific MRI grading of soft tissue involvement provides additional prognostic value beyond skull base criteria in nasopharyngeal carcinoma: a retrospective study.
   BMC Cancer. 2025;25:1751.
   PubMed         Abstract available
   
   
6. PENG Y, Huang K, Gong Z, Liu W, et al
   Nonenhanced CT-Based radiomics model enhances PTC detection in Hashimoto's thyroiditis.
   BMC Cancer. 2025;25:1760.
   PubMed         Abstract available
   
   

   
   Dis Esophagus

7. TOSHIYAMA S, Honda M, Murakami M, Kikuchi Y, et al
   Proton beam-based chemoradiotherapy versus surgery plus adjuvant chemotherapy for esophageal squamous cell carcinoma: a comparison of the long-term survival from a single-center cohort study.
   Dis Esophagus. 2025;38:doaf099.
   PubMed         Abstract available
   
   
8. JONES DG, Grimminger P, Reynolds J, Rosati R, et al
   Toward standardization in esophageal cancer surgery: patterns of practice across high-volume European centers.
   Dis Esophagus. 2025;38:doaf100.
   PubMed         Abstract available
   
   

   
   Histopathology

9. SUN M, Fu L, Ren H, Wang J, et al
   Two similar but distinct types of breast acinar cell carcinoma: evidence from histological, immunohistochemical and molecular features.
   Histopathology. 2025;87:904-914.
   PubMed         Abstract available
   
   
10. BELL PD, Kaul V, Bittner KM, Chen IY, et al
    Margin clearance and post-procedure ablation decrease recurrence risk in endoscopic mucosal resections for Barrett's-related neoplasia.
    Histopathology. 2025;87:856-868.
    PubMed         Abstract available
    
    

    
    Hum Pathol

11. BEDELL M, Skaugen JM, Nikiforov Y, Reyes-Mugica M, et al
    Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in the adolescent and young adult population: A pediatric center experience.
    Hum Pathol. 2025;165:105951.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. WANG Y, Xi Y, Qiao L, Yu Y, et al
    Ethnic, sex, and age disparities in esophageal cancer and medical costs: A population-based study of 18 million people in China.
    Int J Cancer. 2025 Nov 11. doi: 10.1002/ijc.70236.
    PubMed         Abstract available
    
    

    
    Oral Oncol

13. VAN LOOCKE P, Beuselinck B, Meulemans J, Nuyts S, et al
    Impact of time-of-day administration of immune checkpoint inhibitors on survival outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC): a retrospective cohort study.
    Oral Oncol. 2025;171:107772.
    PubMed        
    
    
14. DIEZ-FRAILE A, Pottel L, Lamoral P, De Backer T, et al
    Age and surgical complexity outperform preoperative Geriatric-8 for 30-day major complications in older head and neck cancer.
    Oral Oncol. 2025;171:107774.
    PubMed        
    
    
15. DOERFLER R, Chen J, Kim C, Smith JD, et al
    Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer.
    Oral Oncol. 2025;171:107742.
    PubMed         Abstract available
    
    
16. OKURA M, Yamakawa N, Otsuru M, Hasegawa T, et al
    T4a classification for oral cancer using mandibular canal invasion instead of bone marrow invasion in the TNM staging system.
    Oral Oncol. 2025;171:107771.
    PubMed         Abstract available
    
    
17. ZHANG Y, Liu Z, Wu C, Li G, et al
    Determination of the pathological staging of the oral squamous cell carcinoma based on microscopic hyperspectral imaging.
    Oral Oncol. 2025;170:107686.
    PubMed         Abstract available
    
    
18. ZHANG Q, Luo X, Fu M, Peng B, et al
    Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma.
    Oral Oncol. 2025;170:107695.
    PubMed         Abstract available
    
    
19. GONG J, Han B, Tang X, Men Y, et al
    Intraoral microvascular anastomosis: A minimally invasive technique for lateral arm free flap tongue reconstruction.
    Oral Oncol. 2025;170:107656.
    PubMed         Abstract available
    
    
20. PALATNIK B, Kazadi D, Jethwa A, Nelson A, et al
    Genomic evolution of a metastatic oral squamous cell carcinoma: a case report, molecular analysis, and review of the literature.
    Oral Oncol. 2025;170:107734.
    PubMed         Abstract available
    
    
21. MARUDHUPANDI T
    Letter to the Editor: Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma.
    Oral Oncol. 2025;170:107740.
    PubMed         Abstract available
    
    
22. HE X, Xu Y, Ren Y, Wang J, et al
    Neoadjuvant chemotherapy combined with anti-PD-1 monoclonal antibody in locally advanced resectable oral squamous cell carcinoma: efficacy evaluation and prediction.
    Oral Oncol. 2025;170:107744.
    PubMed         Abstract available
    
    
23. MARUDHUPANDI T
    Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2025;170:107746.
    PubMed         Abstract available
    
    
24. LI R, Ma S, Tang T, Zhao Y, et al
    Prognostic impact and risk factors of level IV/V lymph nodes metastasis in laryngeal squamous cell carcinoma.
    Oral Oncol. 2025;170:107758.
    PubMed         Abstract available
    
    
25. ZHAO P, Shen Q, Wang J, Chen Y, et al
    Prognostic factors of head and neck osteosarcoma: A 10-year retrospective study from a single institute.
    Oral Oncol. 2025;170:107759.
    PubMed         Abstract available
    
    
26. MARUDHUPANDI T
    Letter to the Editor: Developing a predictive nomogram model for incidence of adverse outcomes in oral and maxillofacial tumor patients undergoing free flap reconstruction.
    Oral Oncol. 2025;170:107751.
    PubMed         Abstract available
    
    
27. WILLIAMS MM, Hanna GJ, Sethi RK, Rettig EM, et al
    Outcomes of oropharyngeal squamous cell carcinoma among patients with lymphoproliferative disorders.
    Oral Oncol. 2025;170:107761.
    PubMed         Abstract available
    
    

    
    Otolaryngol Head Neck Surg

28. ROSEN R, Richter J, Cabrera CI, Karasik D, et al
    Long-Term Opioid Use After Treatment of Head and Neck Cancers: A Systematic Review and Meta-analysis.
    Otolaryngol Head Neck Surg. 2025 Nov 12. doi: 10.1002/ohn.70024.
    PubMed         Abstract available
    
    

    
    PLoS One

29. LABOREY M, Lajoinie A, Freilich J, Samalin E, et al
    Methodological approach to optimize a step-by-step deterministic linkage of SNDS data with a clinical database (FREGAT) of gastric/gastroesophageal junction adenocarcinoma in France: Pitfalls and learnings.
    PLoS One. 2025;20:e0333667.
    PubMed         Abstract available
    
    
30. CHOI YK, Son SH, Jang HS, Kim IH, et al
    Prognostic role of effective radiation dose to immune cells in esophageal cancer treated with definitive chemoradiation.
    PLoS One. 2025;20:e0336794.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

31. VISCHIONI B, Bonora M, Fontana G, Scardo S, et al
    Prognostic factors and clinical outcomes in a large cohort of head and neck adenoid cystic carcinoma patients treated with proton beam therapy: Insights from an Italian referral center.
    Radiother Oncol. 2025;213:111143.
    PubMed         Abstract available
    
    
32. ALYAMANI N, Abrunhosa-Branquinho A, Corning C, Sharabiani M, et al
    Radiotherapy quality assurance of the prospective randomised EORTC-1219/DAHANCA-29 trial: an individual case review analysis.
    Radiother Oncol. 2025;213:111141.
    PubMed         Abstract available
    
    
33. JIANG W, Xiao Y, Hu H, Li J, et al
    Postoperative Intensity-Modulated radiotherapy with trigeminal nerve pathway delineation for head and neck adenoid cystic carcinoma.
    Radiother Oncol. 2025;213:111174.
    PubMed         Abstract available
    
    

    
    Thyroid

34. VAN DE BERG DJ, Vriens MR, van Santen HM, Seur A, et al
    Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi Study.
    Thyroid. 2025 Nov 7. doi: 10.1177/10507256251390871.
    PubMed         Abstract available
    
    
35. SCHONEBAUM LE, Oudijk L, Stegenga MT, Bramer WM, et al
    The Prognostic Value of Immunohistochemical Biomarkers in Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
    Thyroid. 2025 Nov 6. doi: 10.1177/10507256251393208.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.